The double-edge sword of CRISPR application for in vivo studies
A new editorial paper titled "The double-edge sword of CRISPR application for in vivo studies" has been published inOncotarget.
Nov 28, 2023
0
0
A new editorial paper titled "The double-edge sword of CRISPR application for in vivo studies" has been published inOncotarget.
Nov 28, 2023
0
0
A study by researchers at the Brown University School of Public Health on ways to mitigate the impacts of misleading COVID-19 information found that variations in the designs of prior studies have complicated efforts at drawing ...
Nov 17, 2023
1
19
A new research paper titled "FAAH inhibition ameliorates breast cancer in a murine model" has been published in Oncotarget.
Nov 1, 2023
0
0
A new editorial perspective was published in Oncotarget, titled "STAT3 as a biologically relevant target in H3K27M-mutant diffuse midline glioma."
Oct 10, 2023
0
1
Three studies by CUNY SPH investigators highlight the need for stronger guidance on research ethics for using data from social media platforms in public health research, especially the use of personal identifiers.
Oct 6, 2023
0
5
"I didn't know I had a vulva until I was diagnosed with lichen sclerosus and stage three vulval cancer."
Sep 6, 2023
0
4
A new research perspective titled "Adopted neoplastic cells and the consequences of their existence" has been published in Oncotarget.
Aug 29, 2023
0
22
Many Americans don't understand a lot about their health. Whether due to people believing conspiracy theories or simply walking out of their doctor's offices without a good idea of what was said, communicating what scientists ...
Aug 17, 2023
0
4
A new review paper was published in Oncotarget entitled, "Peripheral surrogates of tumor burden to guide chemotherapeutic and immunotherapeutic strategies for HPV-associated malignancies."
Aug 14, 2023
0
11
A new research paper was published in Oncotarget, titled "The uncharacterized transcript KIAA0930 confers a cachexic phenotype on cancer cells."
Jul 26, 2023
0
1